How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study

por Tsai, Shu-Mei, Kao, Jung-Ta, Tsai, Yun-Fang
Publicado 2016

IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study

por Kao, Jung-Ta, Feng, Chun-Lung, Yu, Cheng-Ju, Tsai, Shu-Mei, Hsu, Ping-Ning, Chen, Yao-Li, Wu, Yi-Ying
Publicado 2015